Activin in cerebral hypoxia and acute focal ischemia
激活素在脑缺氧和急性局灶性缺血中的作用
基本信息
- 批准号:7275205
- 负责人:
- 金额:$ 3.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:ActivinsAcuteAntibodiesAstrocytesBiological AssayBrainBrain Hypoxia-IschemiaCell SurvivalCellsCerebral HypoxiaCerebral IschemiaCerebral Ischemia-HypoxiaCerebrumConditionDataDevelopmentEndothelial CellsEquilibriumErythropoietinExposure toGene ExpressionGene TargetingGenesGlucoseGrowth FactorHealthHourHypoxiaImmunochemistryIn Situ HybridizationIn VitroIndividualInfarctionInfectionInjuryIschemiaIschemic PreconditioningIschemic StrokeLeadLifeLinkLocationMediatingMessenger RNAMicrogliaMolecularMorbidity - disease rateMusNeuronsOxidative StressOxygenPathway interactionsPatternPharmaceutical PreparationsProteinsReactionRoleSignal PathwaySignal TransductionStimulusStrokeTestingTimeUnited StatesVascular Endothelial Growth Factorsbasecell typecytokinedeprivationdisabilityhypoxia inducible factor 1inhibitor/antagonistintercellular communicationmRNA Expressionmortalitymouse modelneuronal survivalneutralizing antibodynovelpreconditioningrelating to nervous systemresponsesensorsmall moleculestroke therapytranscription factor
项目摘要
DESCRIPTION (provided by the applicant)
Stroke is an enormous health challenge in the United States with over 700,000 people suffering from a
brain attack every year with many of these individuals living with significant disabilities. Neurons respond to an ischemic stroke by activating signaling pathways and increasing gene expression. One approach for developing targeted stroke therapies is to identify the function of endogenous signals that increase following an ischemic insult. A second approach is to determine which genes are upregulated following nonlethal ischemic preconditioning, a mechanism that can partially alleviate neural damage if a preconditioning stimulus is given prior to a severe insult. The identification of the HIF-1 protein as a critical sensor of oxygen levels has lead to a greater understanding of the cellular and molecular sensing mechanisms involved in cerebral hypoxia and ischemia. Several HIF-1 target genes include growth factors which have been linked to neural protection against ischemic insult. This proposal tests the effect of HIF-1a stabilization on the growth factor activin and examines if activin actions promote neuronal survival in the setting of ischemic preconditioning. Preliminary results indicate that activin mRNA expression increases following hypoxia and acute ischemic injury and that added activin protects neuronal cells from oxidative stress in vitro. We hypothesize that HIF-1 activity results in increased activin expression and in addition, we propose that increased neural survival observed with ischemic preconditioning involves activin actions. Specific aim 1 tests if increases in HIF-1 activity in mice result in the induction of activin mRNA and smad2/3 activation. Specific aim 2 will examine the essential function of activin intracellular signaling in ischemic preconditioning in vitro. Specific aim 3 identifies which cell types synthesize activin and respond to its actions following a mouse model of focal cerebral ischemia. This proposal potentially identifies a novel HIF-1 target in cortical neurons and implicates activin and its signals in both ischemia and preconditioning effects.
描述(由申请人提供)
在美国,中风是一个巨大的健康挑战,超过70万人患有中风
每年,这些人中的许多人都患有严重的残疾。神经元通过激活信号通路和增加基因表达来应对缺血性中风。开发有针对性的中风治疗的一种方法是确定在缺血性损伤后增加的内源性信号的功能。第二种方法是确定哪些基因在非致命性缺血预适应后上调,如果在严重侮辱之前给予预适应刺激,这种机制可以部分减轻神经损伤。HIF-1蛋白是氧水平的重要感受器,这一发现有助于我们更好地理解脑缺氧和脑缺血的细胞和分子传感机制。几个HIF-1靶基因包括生长因子,这些生长因子与防止缺血性损伤的神经保护有关。这项建议测试了HIF-1a稳定化对生长因子激活素的影响,并检查在缺血预适应的背景下,激活素的作用是否促进神经元存活。初步结果表明,在缺氧和急性缺血损伤后,激活素的mRNA表达增加,在体外添加激活素可以保护神经细胞免受氧化应激的影响。我们假设HIF-1活性导致激活素表达增加,此外,我们认为缺血预适应所观察到的神经元存活率增加与激活素作用有关。特定目的1测试小鼠HIF-1活性增加是否导致激活素mRNA和Smad2/3激活。特定目的2将在体外研究激活素细胞内信号在缺血预适应中的基本功能。特定目标3确定哪些细胞类型合成激活素,并在小鼠局部脑缺血模型后对其行为做出反应。这一建议潜在地确定了皮质神经元中的一个新的HIF-1靶点,并涉及到激活素及其信号在缺血和预适应效应中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shibani Sharon Mukerji其他文献
Shibani Sharon Mukerji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shibani Sharon Mukerji', 18)}}的其他基金
Characterizing HIV-1 reservoirs in the central nervous system
中枢神经系统中 HIV-1 储存库的特征
- 批准号:
10772268 - 财政年份:2023
- 资助金额:
$ 3.27万 - 项目类别:
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living with HIV.
体内靶向神经活性类固醇和免疫网络治疗艾滋病毒感染者的抑郁症。
- 批准号:
10535147 - 财政年份:2022
- 资助金额:
$ 3.27万 - 项目类别:
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living with HIV.
体内靶向神经活性类固醇和免疫网络治疗艾滋病毒感染者的抑郁症。
- 批准号:
10843494 - 财政年份:2022
- 资助金额:
$ 3.27万 - 项目类别:
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living with HIV.
体内靶向神经活性类固醇和免疫网络治疗艾滋病毒感染者的抑郁症。
- 批准号:
10701054 - 财政年份:2022
- 资助金额:
$ 3.27万 - 项目类别:
Immune Activation, Cerebral Metabolic Activity and Depression in Treated HIV-Infection
HIV 感染治疗中的免疫激活、大脑代谢活动和抑郁
- 批准号:
10339397 - 财政年份:2018
- 资助金额:
$ 3.27万 - 项目类别:
Activin in cerebral hypoxia and acute focal ischemia
激活素在脑缺氧和急性局灶性缺血中的作用
- 批准号:
7670508 - 财政年份:2007
- 资助金额:
$ 3.27万 - 项目类别:
Activin in cerebral hypoxia and acute focal ischemia
激活素在脑缺氧和急性局灶性缺血中的作用
- 批准号:
7677913 - 财政年份:2007
- 资助金额:
$ 3.27万 - 项目类别:
相似海外基金
Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection
急性和持续性 Epstein-Barr 病毒感染中的中和抗体
- 批准号:
9182818 - 财政年份:2014
- 资助金额:
$ 3.27万 - 项目类别:
Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection
急性和持续性 Epstein-Barr 病毒感染中的中和抗体
- 批准号:
8965501 - 财政年份:2014
- 资助金额:
$ 3.27万 - 项目类别:
Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection
急性和持续性 Epstein-Barr 病毒感染中的中和抗体
- 批准号:
8854409 - 财政年份:2014
- 资助金额:
$ 3.27万 - 项目类别:
Development ofTherapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells
针对人急性髓性白血病干细胞的治疗性抗体的开发
- 批准号:
G1000729/1 - 财政年份:2010
- 资助金额:
$ 3.27万 - 项目类别:
Research Grant
The relationship between anti-donor antibodies and acute rejection in lung transplantation
抗供体抗体与肺移植急性排斥反应的关系
- 批准号:
12671311 - 财政年份:2000
- 资助金额:
$ 3.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
NON-NEUTRALIZING ANTIBODIES IN ACUTE PRIMARY HIV INFECTION
急性原发性 HIV 感染中的非中和抗体
- 批准号:
6347230 - 财政年份:2000
- 资助金额:
$ 3.27万 - 项目类别:
NON-NEUTRALIZING ANTIBODIES IN ACUTE PRIMARY HIV INFECTION
急性原发性 HIV 感染中的非中和抗体
- 批准号:
6201348 - 财政年份:1999
- 资助金额:
$ 3.27万 - 项目类别:
NON-NEUTRALIZING ANTIBODIES IN ACUTE PRIMARY HIV INFECTION
急性原发性 HIV 感染中的非中和抗体
- 批准号:
6100126 - 财政年份:1998
- 资助金额:
$ 3.27万 - 项目类别:
NON-NEUTRALIZING ANTIBODIES IN ACUTE PRIMARY HIV INFECTION
急性原发性 HIV 感染中的非中和抗体
- 批准号:
6235545 - 财政年份:1997
- 资助金额:
$ 3.27万 - 项目类别:
MONOCLONAL ANTIBODIES FOR THE TREATMENT OF ACUTE MYELOGE
用于治疗急性脊髓病的单克隆抗体
- 批准号:
3169988 - 财政年份:1983
- 资助金额:
$ 3.27万 - 项目类别: